Private importing
Shopping Guide
    Request Form     Request Form for Corporate Service

Product Overview/Feature

  • JP

Code:005287-002

Tsumura Eppikajututo[28] : 42 sachets(for two weeks)

Sale Price:US$27.49

Warehouse Japan1
Manufacturer TSUMURA & CO.
Brand TSUMURA & CO.
JAN Code ---
GS1 ---
Ingredient Code 5200007
Shipping Schedule about 3 weeks after payment

Description

Eppikajutsuto is indicated for the relief of the following symptoms of those patients with edema, diaphoresis, and difficulty in micturition:Nephritis, nephrosis, beriberi, articular rheumatism, nocturnal enuresis, and eczema

Presentation

42 sachets

Feature

Granules

Active Ingredients

7.5 g (3 sachets for 1day)of TSUMURA Eppikajutsuto extract granules contains 3.25 g of a dried extract of the following mixed crude drugs.JP Gypsum 8.0 gJP Ephedra Herb 6.0 gJP Atractylodes Lancea Rhizome 4.0 gJP Jujube 3.0 gJP Glycyrrhiza 2.0 gJP Ginger 1.0 g(JP: The Japanese Pharmacopoeia)

Effect/Efficacy

Eppikajutsuto is indicated for the relief of the following symptoms of those patients with edema, diaphoresis, and difficulty in micturition: Nephritis, nephrosis, beriberi, articular rheumatism, nocturnal enuresis, and eczema

Usage/Dosage

The usual adult dose is 7.5 g/day orally in 2 or 3 divided doses before or between meals. The dosage may be adjusted according to the patient's age and body weight, and symptoms.

Cautions

1. Careful administration (Eppikajutsuto should be administered with care in the following patients.) (1) Patients in a period of weakness after disease or with greatly declined constitution [Adverse reactions are likely to occur, and the symptoms may be aggravated.]
(2) Patients with a weak gastrointestinal tract [Anorexia, epigastric distress, nausea, vomiting, soft feces, diarrhea, etc. may occur.] (3) Patients with anorexia, nausea or vomiting [These symptoms may be aggravated.] (4) Patients showing a remarkable tendency of sweating [Excess sweating and/or generalized weakness may occur.] (5) Patients with cardiovascular disorders including angina pectoris and myocardial infarction, etc. or those with a history of such disorders. (6) Patients with severe hypertension (7) Patients with severe renal dysfunction (8) Patients with dysuria (9) Patients with hyperthyroidism [(5)-(9): These disease and symptoms may be aggravated.]

Contraindication